Skip to main content

ADVERTISEMENT

glioblastoma

Research in Review
04/03/2017
JCP Editors
A combination therapy for patients with newly diagnosed glioblastoma maintains improvement in overall survival (OS) after 5 years, according to recently published results of a phase III trial. ----- Related...
A combination therapy for patients with newly diagnosed glioblastoma maintains improvement in overall survival (OS) after 5 years, according to recently published results of a phase III trial. ----- Related...
A...
04/03/2017
Journal of Clinical Pathways